Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes

International Journal of COPD

Volumn 9, Issue , 2014, Pages 1145-1154

  Aryal, Shambhu ^a   Diaz Guzman, Enrique ^b   Mannino, David M ^c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Chronic obstructive lung disease; Comorbidity; Sex; Sex bias; Smoking

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; INFLUENZA VACCINE; MACROLIDE; OXYGEN; PNEUMOCOCCUS VACCINE;

ASTHMA; BACTERIAL INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CLINICAL RESEARCH; COMORBIDITY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; HOSPITALIZATION; HUMAN; INDOOR AIR POLLUTION; INFLUENZA; KINESIOTHERAPY; MOLECULAR GENETICS; MORTALITY; NUTRITIONAL COUNSELING; OCCUPATIONAL EXPOSURE; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATHOGENESIS; PATIENT EDUCATION; PHENOTYPIC VARIATION; PNEUMOCOCCAL INFECTION; PREVALENCE; PULMONARY REHABILITATION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; VIRUS INFECTION; ADVERSE EFFECTS; AGED; FEMALE; HEALTH CARE DISPARITY; HEALTH DISPARITY; LUNG; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; LUNG; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEX FACTORS; SMOKING; TREATMENT OUTCOME;

EID: 84907878191     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S54476     Document Type: Review

References (81)

1. Murphy SL, Xu J, Kochanek KD. Deaths: Final Data for 2010. Nat Vital Stat Rep. 2013;61:1-117.
2. World Health Organization. World Health Statistics: 2008. Geneva: WHO; 2008. Available from: http://www.who.int/whosis/whostat/EN_WHS08_Full.pdf. Accessed June 1, 2014.
3. US Department of Health and Human Services. The Health Consequences of Smoking - 50 Years of Progress. A Report of the Surgeon General - Executive Summary. Rockville (MD): HSS; 2014. Available from: http://www.surgeongeneral.gov/library/reports/50-years-of-progress/exec-summary.pdf. Accessed June 2, 2014.
4. Burns D, Major J, Shanks T. Changes in number of cigarettes smoked per day: cross-sectional and birth cohort analyses using NHIS. In: Ruppert W, editor. Those Who Continue to Smoke: Is Achieving Abstinence Harder and Do We Need to Change Our Interventions? Collingdale (PA): Diane; 2004:83-99.
5. Mackay J, Amos A. Women and tobacco. Respirology. 2003;8: 123-130.
6. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-202: Global Burden of Disease Study. Lancet. 1997;349:1498-1504.
7. Martinez FJ, Curtis JL, Sciurba FC, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med. 2007;176:243-252.
8. Gan WQ, Man SF, Postma DS, Camp P, Sin DD. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res. 2006;7:52.
9. Sørheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 2010;65:480-485.
10. Silverman E, Weiss S, Drazen J, et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162:2152-2158.
11. Han MK, Postma D, Mannino D, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007;176:1179-1184.
12. Van Winkle LS, Gunderson AD, Shimizu JA, Baker GL, Brown CD. Gender differences in naphthalene metabolism and naphthalene-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2002;282:L1122-L1134.
13. Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182:693-718.
14. Diaz-Guzman E, Aryal S, Mannino DM. Occupational chronic obstructive pulmonary disease: an update. Clin Chest Med. 2012;33: 625-636.
15. Sin DD, Cohen SB, Day A, Coxson H, Paré PD. Understanding the biological differences in susceptibility to chronic obstructive pulmonary disease between men and women. Proc Am Thorac Soc. 2007;4: 671-674.
16. Varkey AB. Chronic obstructive pulmonary disease in women: exploring gender differences. Curr Opin Pulm Med. 2004;10:98-103.
17. Diaz-Guzman E, Mannino DM. Airway obstructive diseases in older adults: from detection to treatment. J Allergy Clin Immunol. 2010;126:702-709.
18. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest. 2004;126:59-65.
19. Kynyk JA, Mastronarde JG, McCallister JW. Asthma, the sex difference. Curr Opin Pulm Med. 2011;17:6-11.
20. Foreman MG, Zhang L, Murphy J, et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med. 2011;184(4):414-420.
21. Global initiative for chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Bethesda (MD): GOLD; 2013.
22. Falagas ME, Mourtzoukou EG, Vardakas KZ. Sex differences in the incidence and severity of respiratory tract infections. Respir Med. 2007;101:1845-1863.
23. Camp PG, Goring SM. Gender and the diagnosis, management, and surveillance of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007;4:686-691.
24. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveill Summ. 2002;51:1-16.
25. Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009. 2011. Available from: http://www.cdc.gov/nchs/data/databriefs/db63.htm. Accessed August 4, 2014.
26. Gershon AS, Wang C, Wilton AS, Raut R, To T. Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in Ontario, Canada, 1996 to 2007: a population-based study. Arch Intern Med. 2010;170:560-565.
27. Bischoff EW, Schermer TR, Bor H, Brown P, van Weel C, van den Bosch WJ. Trends in COPD prevalence and exacerbation rates in Dutch primary care. Br J Gen Pract. 2009;59:927-933.
28. Schirnhofer L, Lamprecht B, Vollmer WM, et al. COPD prevalence in Salzburg, Austria: results from the Burden of Obstructive Lung Disease (BOLD) study. Chest. 2007;131:29-36.
29. Menezes AM, Perez-Padilla R, Jardim JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet. 2005;366:1875-1881.
30. Bhome AB. COPD in India: iceberg or volcano? J Thorac Dis. 2012;4:298-309.
31. Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176:753-760.
32. Han MK, Postma D, Mannino D, et al. Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med. 2007;176:1179-1184.
33. Burrows B, Boom J, Traver G, Cline M. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 1987;317:1209-1214.
34. Centers for Disease Control and Prevention. National Center for Health Statistics: National Health Interview Survey raw data, 2011. Available from: http://www.cdc.gov/nchs/nhis/nhis_2011_data_release.htm. Accessed September 9, 2014.
35. Martinez F, Curtis J, Sciurba F, et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med. 2007;176:243-252.
36. Celli BR, Halbert RJ, Nordyke RJ, et al. COPD in never smokers: a significant problem? Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey. Am J Med. 2005;118:1364-1372.
37. Birring S, Brightling C, Bradding P, et al. Clinical, radiologic and induced sputum features of chronic obstructive pulmonary disease in nonsmokers: a descriptive study. Am J Respir Crit Care Med. 2002;166: 1078-1083.
38. Kohler M, Sandberg A, Kjellqvist S, et al. Gender differences in the bronchoalveolar lavage cell proteome of patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2013;131:743-751.
39. Aryal S, Diaz-Guzman E, Mannino DM. COPD and gender differences: an update. Transl Res. 2013;162:208-218.
40. Watson L, Vestbo J, Postma DS, et al. Gender differences in the management and experience of chronic obstructive pulmonary disease. Respir Med. 2004;98:1207-1213.
41. de Torres JP, Casanova C, Hernández C, Abreu J, Aguirre-Jaime A, Celli BR. Gender and COPD in patients attending a pulmonary clinic. Chest. 2005;128:2012-2016.
42. Cydulka RK, Rowe BH, Clark S, Emerman CL, Rimm AR, Camargo CA. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbations. Acad Emerg Med. 2005;12:1173-1179.
43. Ancochea J, Miravitlles M, García-Río F, et al. Under-diagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch Bronconeumol. 2013;49:223-229.
44. Lopez Varela MV, Montes de Oca M, Halbert RJ, et al. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J. 2010;36:1034-1041.
45. Agusti A, Calverley PM, Celli B, et al. Characterization of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122.
46. Celli B, Vestbo J, Jenkins CR, et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med. 2011;183:317-322.
47. Watson L, Vonk JM, Lofdahl CG, et al. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study. Respir Med. 2006;100:746-753.
48. Becklake MR, Kauffmann F. Gender differences in airway behavior over the human life span. Thorax. 1999;54:1119-1138.
49. Verhage TL, Heijdra Y, Molema J, Vercoulen J, Dekhuijzen R. Associations of muscle depletion with health status. Another gender difference in COPD? Clin Nutr. 2011;30:332-338.
50. Chapman KR, Tashkin DP, Pye DJ. Gender bias in the diagnosis of COPD. Chest. 2001;119:1691-1695.
51. Miravitlles M, de la Roza C, Naberan K, et al. [Attitudes toward the diagnosis of chronic obstructive pulmonary disease in primary care]. Arch Bronconeumol. 2006;42:3-8. Spanish.
52. Martinez CH, Raparla S, Plauschinat CA, et al. Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J Womens Health (Larchmt). 2012;21:1267-1274.
53. Almagro P, López García F, Cabrera F, et al. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med. 2010;104:253-259.
54. Ekström MP, Jogréus C, Ström KE. Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease. PLoS One. 2012;7:e35806.
55. Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100:1767-1774.
56. Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26:414-419.
57. Hanania NA, Müllerova H, Locantore NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011;183:604-611.
58. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care. 2001;46:798-825.
59. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000;161:381-390.
60. Jarvis MJ, Cohen JE, Delnevo CD, Giovino GA. Dispelling myths about gender differences in smoking cessation: population data from the USA, Canada and Britain. Tob Control. 2013;22:356-360.
61. Vestbo J, Soriano JB, Anderson JA, Calverley P, Pauwels R, Jones P. Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD. Respir Med. 2004;98: 1045-1050.
62. O'Donnell DE, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23:832-840.
63. Watson L, Schouten JP, Lofdahl CG, Pride NB, Laitinen LA, Postma DS. Predictors of COPD symptoms: does the sex of the patient matter? Eur Respir J. 2006;28:311-318.
64. Hubbard RB, Smith CJ, Smeeth L, Harrison TW, Tattersfield AE. Inhaled corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med. 2002;166:1563-1566.
65. Schermer TR, Hendriks AJ, Chavannes NH, et al. Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice. Prim Care Respir J. 2004;13:48-55.
66. Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365:689-698.
67. Dales RE, Mehdizadeh A, Aaron SD, Vandemheen KL, Clinch J. Sex differences in the clinical presentation and management of airflow obstruction. Eur Respir J. 2006;28:319-322.
68. Sestini P, Cappiello V, Aliani M, et al. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med. 2006;19:127-136.
69. Crockett AJ, Cranston JM, Moss JR, Alpers JH. Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting. Intern Med J. 2001;31:448-454.
70. Machado MC, Krishnan JA, Buist SA, et al. Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174:524-529.
71. Schwartz AW, Clarfield AM, Doucette J, et al. Disparities in pneumococcal and influenza immunization among older adults in Israel: a cross-sectional analysis of socio-demographic barriers to vaccination. Prev Med. 2013;56:337-340.
72. Foy CG, Rejeski WJ, Berry MJ, Zaccaro D, Woodard CM. Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients. Chest. 2001;119:70-76.
73. Haggerty MC, Stockdale-Woolley R, Zuwallack R. Functional status in pulmonary rehabilitation participants. J Cardiopulm Rehabil. 1999;19:35-42.
74. de Torres Tajes JP, Casanova C, Hernández C, et al. Gender associated differences in determinants of quality of life in patients with COPD: a case series study. Health Qual Life Outcomes. 2006;4:72.
75. Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology. 2006;11:188-195.
76. Gonzalez AV, Suissa S, Ernst P. Gender differences in survival following hospitalisation for COPD. Thorax. 2011;66:38-42.
77. Patil SP, Krishnan JA, Lechtzin MD, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 2003;163:1180-1186.
78. de Torres JP, Cote C, López MV, et al. Sex differences in mortality in patients with COPD. Eur Respir J. 2009;33:528-535.
79. Ford ES, Mannino DM, Zhao G, Li C, Croft JB. Changes in mortality among US adults with COPD in two national cohorts recruited from 1971-1975 and 1988-1994. Chest. 2012;141:101-110.
80. Thun MJ, Carter BD, Feskanich D, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368:351-364.
81. Burney P, Jithoo A, Kato B, et al. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty - a BOLD analysis. Thorax. 2014;69:465-473.